Cargando…
The Promise of Personalized TCR-Based Cellular Immunotherapy for Cancer Patients
Mutation-derived neoantigens are now established as attractive targets for cancer immunotherapy. The field of adoptive T cell transfer (ACT) therapy was significantly reshaped by tumor neoantigens and is now moving towards the genetic engineering of T cells with neoantigen-specific T cell receptors...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363295/ https://www.ncbi.nlm.nih.gov/pubmed/34394096 http://dx.doi.org/10.3389/fimmu.2021.701636 |